VotedBy VotedBy ⌕
Election Day · Tue, Nov 3See how your members of Congress voted →

H.R. 8540 · 117th Congress

Developing and Nationalizing Key Cannabis Research Act of 2022

Key: what the circles and colors mean

Each circle is a bill. The ring fills as it moves through Congress:

IntroducedPassed one chamberPassed both chambersBecame law (gold)Resolution agreed to (full, dark)Failed or vetoed (gray)

Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.

Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.

Never voted on. It didn't reach a floor vote before the 117th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.

1 cosponsor · 1 R

1 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.

Developing and Nationalizing Key Cannabis Research Act of 2022 This bill directs the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC) to expand activities concerning cannabis research. The NIH must collaborate with specified agencies to develop a national cannabis research agenda.

What it does: CRS summary · Introduced in House · Jul 27, 2022

Developing and Nationalizing Key Cannabis Research Act of 2022

This bill directs the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC) to expand activities concerning cannabis research.

The NIH must collaborate with specified agencies to develop a national cannabis research agenda. Among other topics, the agenda must address (1) the therapeutic benefits of cannabis, (2) how cannabis effects specified populations, and (3) other public safety considerations. Additionally, the NIH must designate centers of excellence in cannabis research at institutions of higher education to conduct interdisciplinary research about biomedical, behavioral, and social issues related to cannabis.

The CDC must work with other agencies to collect population-wide data about cannabis use, including (1) demographic factors, (2) health outcomes, (3) product variety, and (4) other relevant health information.

Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov

About this bill and sources

Official title: Developing and Nationalizing Key Cannabis Research Act of 2022

Latest action (Nov 1, 2022): Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.

Policy area: Health · Origin: House · Introduced: Jul 27, 2022

Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)

No recorded floor vote found.